Team member

Dilyana is an experienced market access professional with 8 years of experience conducting primary and secondary research to evaluate market dynamics and trends across Europe, Canada, Japan, LatAm, and the US. She is experienced in analyzing emerging competitors and market disruptions, supporting commercial execution through launch planning, reimbursement strategies, indication expansion, and performance optimization. Additionally, she can identify opportunities and threats for pipeline therapies by monitoring health technology assessments (HTAs), prescribing trends, and comparator costs in major markets. She is adept at organizing and leading advisory boards to assess clinical data significance and define additional evidence needs for reimbursement dossiers internationally, demonstrating strong cross-functional collaboration and strategic insight in the pharmaceutical and biotech sectors. Her comprehensive approach helps companies navigate market access challenges, secure reimbursement, and achieve timely patient access to innovative therapies. Dilyana has experience across various therapeutic areas including oncology, immunology, metabolic, and rare conditions.